Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

sales@dingminpharma.com

86-311-67591193

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
HomeProductsAPIs And IntermediatesSunitinib Intermediates
PRODUCT CATEGORIES

Sunitinib Intermediates

(Total 5 Products)
CAS 2199-59-9 sunitinib impurity

Unit PriceUSD 6 / Gram

Min.Order Unit Price
1 Gram USD 6 / Gram

Brand: DM

Packaging: double PE with aluminium foil bag

Factory Price Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate CAS 2199-59-9 with purity 99%Min Light Red Powder Strictly Quality Inspection & Timely Delivery & After-Sale Service SupplyAbility 1000 Kilogram/Kilograms per Month CAS...
Good Quality Price Powder Sunitinib Base CAS 557795-19-4

Packaging: As required

Good Quality Price Powder Sunitinib base CAS 557795-19-4 Name: N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide Other name: Sunitinib base; Sunitinib Sutent Specification:...
Sunitinib Malate CAS 341031-54-7 Pharmaceutical Grade

Packaging: As required

Sunitinib malate CAS 341031-54-7 Pharmaceutical Grade GMP ISO Storage:It should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. Name: Sunitinib Malate Specification: 99% CAS NO.: 341031-54-7...
Sunitinib Intermediate low price CAS No 253870-02-9

Packaging: As required

Sunitinib Intermediates 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid cas no 253870-02-9 Sunitinib is a kind of selectively targeting a variety of novel receptor tyrosine kinases in drug first drug.Primary development goal of sunitinib,...
Sunitinib Intermediate 5-Fluoro-2-oxindole CAS:56341-41-4

Packaging: As required

Sunitinib Intermediate 5-Fluoro-2-oxindole CAS:56341-41-4 Name: 5-Fluoro-2-oxindole Other name: 5-FLUORO-1,3-DIHYDRO-2H-INDOL-2-ONE; Specification: Sunitinib Intermediate CAS NO.: 56341-41-4 Appearance: Yellow powder Purity: 99% Molecular...

China Sunitinib Intermediates Suppliers

Sunitinib is the first drug in a new class of drugs that selectively target multiple receptor tyrosine kinases. Inhibition of receptor tyrosine kinases is thought to "starve" tumors by blocking the supply of blood and nutrients needed for tumor growth and has simultaneous tumor cell killing activity, i.e., sunitinib combines with cessation of supply to tumor cells. There are two mechanisms of action: anti-angiogenesis by blood and anti-tumor by directly attacking tumor cells.
Home > Products > APIs And Intermediates > Sunitinib Intermediates

New Products

Related Products List

Home

Product

Phone

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send